AZBio Board Chair

Kevin Parker

Senior Vice President, Operations

CND Life Sciences, Inc.

Trustee, AZAdvances

 

Kevin Parker was elected Chairman of the AZBio Board of Directors in January 2024 after serving as Vice Chair from April through December 2023.

Kevin Parker serves as Senior Vice President, Operations for CND Life Sciences, Inc.  Headquartered in Scottsdale AZ, CND Life Sciences supports the care of patients facing the potential diagnosis of neurodegenerative disease and other neurological conditions. Operating a CLIA-certified and CAP-accredited laboratory in Scottsdale, Arizona, CND developed the Syn-One Test to help clinicians diagnose Parkinson’s disease, dementia with Lewy bodies, and related disorders known as synucleinopathies.

He is also a Trustee for AZAdvances and Founder and Principal Consultant for Footbridge Solutions, a management consulting firm.

His past leadership roles include serving as Vice President, Precision Oncology Business Operations at Exact Sciences.  In this role Kevin led the Arizona team and was responsible for ensuring day to day operations and strategic goals for Exact Sciences’ cancer therapy selection site were met.

Kevin has nearly two decades’ worth of experience in medical devices and diagnostics with a strong background in strategic, operational, and commercial leadership; merger and acquisition integrations; change management; program management; and Lean Six Sigma.

Kevin holds a BS in Chemical Engineering from Worcester Polytechnic University (WPI) and a MS in Chemical Engineering from Massachusetts Institute of Technology (MIT).